Trademarkia Logo

Canada

C$
EliVax
APPROVED

on 3 Feb 2025

Last Applicant/ Owned by

Elixirgen Therapeutics, Inc.

855 N. Wolfe St.Suite 624Baltimore, MD 21205

US

Serial Number

2150753 filed on 1st Dec 2021

Correspondent Address

MOFFAT & CO.

P.O. Box 2088, Station DOttawa

ONTARIO

CA

K1P5W3

EliVax

Trademark usage description

vaccines for human use, vaccines for animals, drugs and vaccines for the treatment of cancer, vaccine adjuvants research and development of vaccines Read More

Classification Information


Class [005]
Vaccines for human use, Vaccines for animals, Drugs and vaccines for the treatment of cancer, Vaccine adjuvants


Classification kind code

11

Class [042]
Research and development of vaccines and medicines


Classification kind code

11

Class [044]
Inoculation of the vaccine


Classification kind code

11

Mark Details


Serial Number

2150753

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 27
on 3rd Feb 2025
Approval Notice Sent
Submitted for opposition 26
on 3rd Feb 2025
Approved
Submitted for opposition 22
on 24th Jan 2025
Search Recorded
Submitted for opposition 287
on 12th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 1st Dec 2021
Filed
Submitted for opposition 1
on 1st Dec 2021
Created
Submitted for opposition 31
on 1st Dec 2021
Formalized